QQ客服 官方微博 反馈留言

	Engineering a novel protease-based Exendin-4 derivative for type 2 antidiabetic therapeutics
	Zhong, Xia[1]; Yang, Shaomin[2,3]; Liu, Tianxiang[1,4]; Ji, Shundong[5]; Hu, Jinrui[1]; Li, Hongjian[1]
	2018
卷号	150页码:841
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4317805
专题	暨南大学
作者单位	1.[1]Jinan Univ, Dept Life Sci & Technol Coll, Guangzhou 510000, Guangdong, Peoples R China 2.[2]Shenzhen Univ, Shenzhen Municipal Peoples Hosp 6, Affiiated Nanshan Peoples Hosp, Dept Pain Med, Shenzhen 518060, Peoples R China 3.[3]Shenzhen Univ, Shenzhen Municipal Peoples Hosp 6, Affiiated Nanshan Peoples Hosp, Shenzhen Municipal Key Lab Pain Med, Shenzhen 518060, Peoples R China 4.[4]Guanhao Biotech Inc, Guangzhou 510000, Guangdong, Peoples R China 5.[5]Soochow Univ, Affiliated Hosp 1, Suzhou 215000, Peoples R China
推荐引用方式 GB/T 7714	Zhong, Xia[1],Yang, Shaomin[2,3],Liu, Tianxiang[1,4],et al. Engineering a novel protease-based Exendin-4 derivative for type 2 antidiabetic therapeutics[J],2018,150:841.
APA	Zhong, Xia[1],Yang, Shaomin[2,3],Liu, Tianxiang[1,4],Ji, Shundong[5],Hu, Jinrui[1],&Li, Hongjian[1].(2018).Engineering a novel protease-based Exendin-4 derivative for type 2 antidiabetic therapeutics.,150,841.
MLA	Zhong, Xia[1],et al."Engineering a novel protease-based Exendin-4 derivative for type 2 antidiabetic therapeutics".150(2018):841.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。